HIGHLIGHTS
- who: Luigi Celio from the Località Montecroce, Desenzano del Garda, BS, Italy have published the research: Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study, in the Journal: (JOURNAL)
- what: In the current analysis, the authors explore the functional impact of DEX-sparing regimens on health-related QoL by using the Functional Living Index-Emesis (FLIE), a validated nausea- and vomiting-specific patient-reported outcome measure. The present analysis provides . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.